| Patient | Sigmund Freud |
|---|---|
| Date of birth | 1952-05-06 |
| Identifiers | MRN HR-ET005-SYN; SSN (made up) 000-05-8403 |
| Document date | 2026-06-15 |
| Author | Anton Reinholt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review, seen the same day by maxillofacial prosthodontics. [S]
Mr. Freud returns two weeks after intake and is seen by Dr. Vasquez-Lindqvist of maxillofacial prosthodontics on the same day. He finished the varenicline starter week and has taken 1 mg twice daily for a week. He has mild nausea when he takes it before breakfast and vivid dreams, and no change in mood. He now smokes about fourteen cigars a day, from twenty, and says the cigars are less satisfying. He is not yet ready to name a quit date but thinks it may be possible within a month. He has not called the quitline. His pain is unchanged at 6 of 10 on acetaminophen 1,000 mg three times daily. Liquids still leak into his nose at times. [S]
| Element | Detail |
|---|---|
| Cigars | About fourteen a day, from twenty |
| Varenicline | 1 mg twice daily for one week; mild nausea before breakfast; vivid dreams |
| Readiness | Considering a quit date within a month |
| Pain | 6 of 10 before today's reline |
| Weight | 58.2 kg |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever; weight stable |
| Ears, nose, mouth, and throat | Positive | Sore spot at the front edge of the defect; nasal leakage of liquids; no bleeding or lump |
| Gastrointestinal | Positive | Mild nausea after the morning dose on an empty stomach |
| Psychiatric | Negative | Vivid dreams; mood steady; no agitation |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Varenicline 0.5 mg oral tablet: one tablet daily for three days, then one tablet twice daily for four days | One tablet daily for three days, then twice daily for four days, after food | Oral route | 2026-06-01 to 2026-06-08 | completed | S |
| Varenicline 1 mg oral tablet, one tablet twice daily after food; planned for at least 24 weeks | One tablet twice daily after food | Oral route | 2026-06-08 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets three times daily (3,000 mg a day) for pain at the maxillectomy site | Two tablets three times daily | Oral route | 2026-06-01 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-06-15 | Body height | 172 | cm | S |
| 2026-06-15 | Body weight | 58.2 | kg | S |
| 2026-06-15 | Body mass index (BMI) [Ratio] | 19.7 | kg/m2 | S |
| 2026-06-15 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-06-15 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-06-15 | Heart rate | 78 | /min | S |
| 2026-06-15 | Respiratory rate | 16 | /min | S |
| 2026-06-15 | Body temperature | 36.6 | Cel | S |
| 2026-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 95 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-06-15 | Pain severity in the past week - 0-10 numeric rating [Reported] | 6 | {score} | S |
Vital signs recorded on 2026-06-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 136/80, pulse 78; weight 58.2 kg |
| Mouth | With the obturator out: 4 mm shallow ulcer with a clean base at the anterior margin of the defect where the flange presses; no induration, mass, white or red patch elsewhere |
| Neck | No lymph nodes felt |
| Respiratory | Clear to auscultation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Tobacco use disorder, severe: about twenty cigars a day for about fifty years, with many failed attempts to stop; synthetic modern episode linked to his documented cigar smoking | active | confirmed | F17.290 | S — Synthetic modern coding; person-first language; not a claim about his real diagnosis. |
| Squamous cell carcinoma of the right hard and soft palate seven years ago, treated by right partial maxillectomy with clear margins (pT2 N0) and no radiation in this synthetic history, with no recurrence on yearly surveillance | active | confirmed | Z85.818 | S — Synthetic modern survivorship coding anchored to his documented 1923 cancer and operation; the modern stage and treatment are synthetic. |
| Acquired defect of the right maxilla and palate after maxillectomy, closed with an obturator prosthesis that is now worn and fits poorly | active | confirmed | Z90.09 | S — Synthetic modern coding anchored to his documented obturator. |
| Hypernasal speech and nasal leakage of liquids from a poorly sealing obturator | active | confirmed | R49.21 | S — Synthetic finding; resolved when the new obturator was fitted. |
| Chronic pain at the maxillectomy site and right cheek, worse where the obturator rubs | active | confirmed | G89.29 | S — Synthetic modern coding anchored to his documented constant mouth pain. |
| Raised LDL cholesterol (126 mg/dL) with a high estimated 10-year cardiovascular risk after fifty years of smoking | active | confirmed | E78.5 | S — Synthetic finding on the intake lipid panel. |
| Weight loss of 4 kg in six months from painful chewing and leakage, with a low albumin | active | confirmed | R63.4 | S — Synthetic finding; resolved as weight and albumin recovered. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Tobacco use (cigars a day), readiness and quit date | Every visit | Completed today | About fourteen cigars a day, from twenty; quit date not yet chosen |
| Medication safety | Varenicline adherence and side effects (nausea, sleep, dreams, mood) | Every visit; at least 12 weeks, extended to 24 weeks or more | Completed today | 1 mg twice daily; mild nausea before breakfast, vivid dreams; no mood change; advised to take after food |
| Self-management | Behavioral support (quitline and clinic sessions) | Weekly calls around the quit date, then every two to four weeks | Deferred | He had not called the quitline in the two weeks since intake. No harm so far: he has cut down by a third. Corrective action: the tobacco treatment nurse enrolled him directly during the visit, and the quitline will call him this week |
| Laboratory | Kidney function for varenicline dosing | Baseline; again if illness or new medicines | Up to date | Creatinine 0.96 mg/dL, eGFR 83 at intake; no dose change needed |
| Examination | Head and neck surveillance examination (mouth, defect and neck) | Yearly by his head and neck surgeon more than five years after treatment; mouth checked at each visit | Completed today | Traumatic ulcer at the defect margin; no mass, induration or white or red patch; neck clear. Yearly surgeon's examination due in about two months |
| Imaging | Head and neck imaging | Only for symptoms or signs more than five years after treatment | Not indicated | Seven years after treatment with no symptoms of recurrence |
| Examination | Obturator fit, seal and hygiene | Every visit | Completed today | Worn, porous obturator with a poor posterior seal; relined and adjusted today by Dr. Vasquez-Lindqvist; new definitive obturator planned |
| Examination | Speech and swallowing (hypernasality, nasal leakage) | Every visit; speech-language therapy as needed | Completed today | Hypernasal speech and nasal leakage before the reline; better with the relined obturator; speech-language therapy planned |
| Self-management | Dental care (high-fluoride toothpaste, cleaning every three months) | Daily toothpaste; cleaning every three months | Completed today | High-fluoride toothpaste advised by Dr. Vasquez-Lindqvist |
| Examination | Osteoradionecrosis, trismus and neck fibrosis | Only after radiation to the head and neck | Not indicated | No radiation in his treatment |
| Laboratory | Thyroid function | Only after radiation to the neck | Not indicated | No neck radiation |
| Examination | Weight and nutrition | Every visit | Completed today | 58.2 kg; soft high-protein diet and supplements twice daily |
| Survey | Pain score and function | Every visit | Completed today | 6 of 10 before the reline |
| Medication safety | Acetaminophen daily dose (no more than 3,000 mg) | Every visit | Completed today | 3,000 mg a day; no other acetaminophen products |
| Medication safety | Opioids | Avoid long-term opioids | Not indicated | Not needed; pain is mechanical and improving with prosthetic care |
| Referral | Maxillofacial prosthodontics consultation | At a worn or poorly sealing obturator | Completed today | Seen by Dr. Vasquez-Lindqvist today |
Goal progress:
Guideline basis: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline (2020); Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021); NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2026 (follow-up and survivorship) (2026); American Cancer Society Head and Neck Cancer Survivorship Care Guideline (2016); CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022)
Follow-up: Quitline call this week. Six-week review in four weeks. Prosthodontic impressions for the new obturator in about four weeks. Next scheduled visit 2026-07-13: six-week review: smoking down by two thirds, setting a quit date, pain and weight. [S]